Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Armen Shanafelt > Profile

Armen Shanafelt

Affiliations

  • Large Shareholder, Director at Surface Oncology Inc. (SURF), 2022-06-11
  • Director at Aeglea Biotherapeutics Inc. (AGLE), 2022-06-10
  • Director at Aileron Therapeutics Inc (ALRN), 2018-06-25
  • Large Shareholder, Director at Protagonist Therapeutics Inc (PTGX), 2018-06-12
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AGLE $3.65 14,685 $53,600.25 150,000 2021-12-13 Filing
AGLE $3.65 13,516 $49,333.40 135,315 2021-12-10 Filing
AGLE $3.67 121,799 $446,758.73 121,799 2021-12-09 Filing
SURF $15.00 266,000 $3,990,000.00 3,447,817 2018-04-23 Filing
ALRN $15.00 250,000 $3,750,000.00 1,094,987 2017-07-05 Filing